$498M awarded to Ten Translational Centers in Renewed Funding

The National Center for Research Resources has awarded a total of $498 million to 10 research institutes to sponsor the second five-year phase of their Clinical and Translational Science Institutes.

The largest funding in the second round of Clinical and Translational Science awards (CTSA) was granted to the University of California, San Francisco ($112 million); the University of Pittsburgh ($67.3 million); Mayo Clinic ($62.8 million); and the University of Pennsylvania ($54.8 million).

The latest CTSA funding was also received by other research centers including Yale University ($45.4 million); Oregon Health & Sciences University ($39.8 million); Columbia University Medical Center ($38.9 million); Rockefeller University ($36.1 million); University of Rochester ($20.7 million); and UC Davis ($20 million).

In a statement from UCSF, the director of the National Center for Research Resources, Barbara Alving said that “These institutes were the pioneers in this program and are to be commended for the work they have done in bridging the traditional divides between laboratory research and medical practice.” Alving added that “They were tasked with transforming the way their institutions coordinate research to make it more proactive and effective in producing real-world results, and in the process, they have served as innovative models nationwide.”

UCSF reveals that a report on the CTSA program, which emphasizes on the research that has commenced from this program, is expected to be released by the National Institutes of Health in August.

According to UCSF, researchers have been enabled to support the creation of a framework using the CTSA grants to “move beyond the traditional silos of science to collaborate on promising research and find the training and resources to move those projects ahead.”

The university said that at UCSF, the funding has enabled the creation of “an extensive network of training and support for researchers to help bridge the gaps between laboratory science, clinical care, and improvements in health.”

Leave a Reply